Health Care/Hospital

ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of attention deficit hyperactivity disorder (ADHD). This milestone represents a substant...

2025-03-24 09:00 3692

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2025-03-24 08:00 3232

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administrati...

2025-03-24 08:00 3143

Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14

* EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. * Preclinical highlights: * EVM14 induced a dose-dependent, antigen-specific immun...

2025-03-24 07:30 2965

Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence

CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: * Volpara density is now a validated input to the BOADICEA breast cancer risk model. * A record of 21 ind...

2025-03-24 05:00 2146

World Oral Health Day 2025

Healthy Teeth, Healthy Life – Experts Urge: "Protect Your Smile, Embrace Confidence" HONG KONG, March 23, 2025 /PRNewswire/ -- A healthy mouth is the foundation of both physical and mental well-being and plays a vital role in enhancing overall quality of life. This year, FDI World Oral Health Da...

2025-03-23 13:27 3220

Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up

SHANGHAI and HONG KONG, March 21, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period endingDecember 31, 2024, along with several significant milestones achieved in recent months. Dr. Jay Mei, Antengene's Founder,...

2025-03-21 19:29 5036

Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results

Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure Data from Multiple Ongoing Late-Stage Studies Reinforce Brii Bio's HBV Functional Cure Strategy of Optimized Combination Regimens to Target...

2025-03-21 19:10 6983

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces thatthe United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix® (TLX007-CDx, ki...

2025-03-21 08:38 2943

VISTA Eye Specialist Expands ESG Commitment with Sponsorship of Destiny Football Development Centre to Empower Youth Through Sports and Vision

PETALING JAYA, Malaysia, March 21, 2025 /PRNewswire/ -- VISTA Eye Specialist, Malaysia's leading eye care provider, proudly announces its sponsorship of Destiny Football Development Centre (Destiny FDC) as part of its continued commitment to Environmental, Social, and Governance (ESG) initiatives...

2025-03-21 08:00 2882

Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

* BPDCN is an aggressive hematologic malignancy with a historically poor prognosis * VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around the world  * VisualDx's system seeks to enhance identification of people who may have BP...

2025-03-20 22:29 3070

CAS announces the participants selected for the 2025 CAS Future Leaders program

The esteemed initiative equips early-career scientists with leadership training and networking opportunities COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society (ACS) specializing in scientific knowledge management, is excited to announce the participa...

2025-03-20 21:00 3624

New Study Reveals NatureKnit™, a Patented, Natural Microbiome Ingredient, Exhibits a More Gentle and Significant Prebiotic Effect Compared with Purified Fibers

MOMENCE, Ill., March 20, 2025 /PRNewswire/ -- New research published in  Microorganisms has revealed the significant impact of NatureKnit™, an all-natural and patent-pending gut health innovation from FutureCeuticals, on the human gut microbiome. The study, conducted in partnership with ProDigest...

2025-03-20 20:00 2880

Ascletis Pharma to Host Obesity Portfolio Webinar on April 2, 2025

HONG KONG, March 20, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces it will host an Obesity Portfolio Webinar onApril 2, 2025 , from9:00 a.m. – 10:30 a.m. ET. The event will include a detailed discussion on Ascletis' obesity portfolio including exciting data about its...

2025-03-20 19:00 4362

A Happy Mouth Is a Happy Mind: FDI World Dental Federation features new song to raise awareness of the link between oral health and mental well-being.

GENEVA, March 20, 2025 /PRNewswire/ -- How does oral health affect mental well-being? This World Oral Health Day (WOHD), the FDI World Dental Federation (FDI) aims to answer that question with a catchy new song, now available onall streaming platforms.

2025-03-20 17:00 3106

Manulife Launches Industry-Leading 'Cancer Drug Support Service' in Collaboration with Prosper Health and Shenzhen New Frontier United Family Hospital

New service enhances customer access to cost-effective cancer medications available in mainlandChina, helping to reduce cancer medication expenses while providing essential support for their treatment journey HONG KONG, March 20, 2025 /PRNewswire/ -- Manulife Hong Kong has collaborated with Pros...

2025-03-20 14:00 2868

Bened Life Leads Advocacy Campaign Alongside Research Innovation During Neurodiversity Celebration Week

FREMONT, Calif., March 20, 2025 /PRNewswire/ -- Bened Life, a pioneering biotechnology company dedicated to advancing mental and neurological health, is announcing an international donation campaign during Neurodiversity Celebration Week. As part of its commitment to fostering innovative solution...

2025-03-20 14:00 3515

BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China

Enhancing Precision and Innovation in Neurosurgical Robotics Across China ZHUBEI, March 20, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac ...

2025-03-20 11:16 2969

HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development

SEOUL, South Korea, March 20, 2025 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing of a Memorandum of Understanding (MOU) with Hallym University Sacred Heart Hospital inSeoul, South Korea. This strategic alliance aims to d...

2025-03-20 11:00 3955

Medit Partners with Imagoworks to Enhance Edentulous Prosthetic Workflow

By integrating Medit SmartX with Imagoworks' AOX, dental professionals can streamline the edentulous prosthetic workflow, ensuring seamless data transfer, precise prosthetic design, and enhanced restoration services for improved patient care. SEOUL, South Korea, March 20, 2025 /PRNewswire/ -- Me...

2025-03-20 09:00 3590
1 ... 125126127128129130131 ... 540